Overview

Oral Clofarabine for Acute Myeloid Leukemia

Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This is a phase I study designed to test the safety of oral clofarabine when given as consolidation therapy to older patients with AML in remission.
Phase:
Phase 1
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Clofarabine